Projects funded by the NCN
Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neuronal cells and transgenic animals.
2022/45/B/NZ7/02419
Keywords:
brain cytochrome P450 dopamine serotonin neuronal cells transgenic animals neurological and psychiatric diseases CRISPR-Cas9 letivirus vector AAV vector HPLC,
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ4_9: Systems neurobiology
- NZ3_6: Cell neurobiology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj.
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 23 - announced on 2022-03-28
Amount awarded: 2 178 906 PLN
Project start date (Y-m-d): 2023-02-03
Project end date (Y-m-d): 2027-02-02
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- The Engagement of Cytochrome P450 Enzymes in Tryptophan MetabolismAuthors:Anna Haduch, Ewa Bromek, Wojciech Kuban, Władysława Anna Daniel (review)Academic press:Metabolites (rok: 2023, tom: 13, strony: 629), Wydawca: MDPIStatus:PublishedDOI:10.3390/metabo13050629 - link to the publication